Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bacillus subtilis comes of age as a vaccine production host and delivery vehicle

31 May 2015

Abstract excerpt

Bacillus subtilis is a vaccine production host and delivery vector with several advantages such as a low production cost, straightforward administration as it is safe for human consumption and the production of spores exerting adjuvant effects. This review summarizes the expression approaches and provides an updated outlook of how a myriad of pathogens have been targeted under this technology. Furthermore, by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Escherichia coli research studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26028252
DOI: 10.1586/14760584.2015.1051469

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bacillus subtilis comes of age as a vaccine production host and delivery vehiclePMID 26028252Read ↗

Application of Bacillus subtilis as a live vaccine vector: A reviewSemantic proximity Read ↗

Progress in Bacillus subtilis Spore Surface Display Technology towards Environment, Vaccine Development, and BiocatalysisSemantic proximity Read ↗

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthraxSemantic proximity Read ↗

In vivo assessment for oral delivery of Bacillus subtilis harboring a viral protein (VP28) against white spot syndrome virus in Litopenaeus vannameiSemantic proximity Read ↗

Advancing vaccine technology through the manipulation of pathogenic and commensal bacteriaSemantic proximity Read ↗

Surface Display of porcine circovirus type 2 antigen protein cap on the spores of bacillus subtilis 168: An effective mucosal vaccine candidateSemantic proximity Read ↗

Technologies for the design, discovery, formulation and administration of vaccines.Semantic proximity Read ↗

Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacteriumSemantic proximity Read ↗

Genome-level therapeutic targets identification and chimeric Vaccine designing against the Blastomyces dermatitidisSemantic proximity Read ↗

Enteric Pathogens as Vaccine Vectors for Foreign Antigen DeliverySemantic proximity Read ↗

A new vaccination approach for Salmonellosis employing a multi-epitope vaccine based on live microbial cell factory from Lactococcus lactisSemantic proximity Read ↗

BCG vaccine’s off-target effects on allergic, inflammatory, and autoimmune diseases: Worth another shot?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.